{
    "organizations": [],
    "uuid": "90b1dcbb95a21e8389a3544e48ace863a38db5f8",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-evolus-announces-update-with-dwp-4/brief-evolus-announces-update-with-dwp-450-regulatory-submissions-idUSFWN1SN0O2",
    "ord_in_thread": 0,
    "title": "BRIEF-Evolus Announces Update With DWP-450 Regulatory Submissions",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 16 (Reuters) - Evolus Inc:\n* EVOLUS ANNOUNCES PROGRESS WITH DWP-450 REGULATORY SUBMISSIONS\n* EVOLUS INC - CONFERENCE CALL SCHEDULED FOR 8:30AM ET / 5:30AM PT\n* EVOLUS INC - EVOLUS RECEIVES FDA COMPLETE RESPONSE LETTER WITH COMMENTS ISOLATED TO CMC ITEMS\n* EVOLUS INC - PLANS TO UTILIZE DAEWOONG FACILITY TO SUPPORT COMMERCIAL PRODUCTION FOLLOWING ANTICIPATED APPROVAL OF DWP-450.\n* EVOLUS INC - FDA ISSUES FAVORABLE EIR LETTER RELATED TO MANUFACTURING FACILITY\n* EVOLUS INC - DWP-450 MANUFACTURING FACILITY IS FULLY VALIDATED BY DAEWOONG UNDER CURRENT GOOD MANUFACTURING PRACTICE REQUIREMENTS\n* EVOLUS INC - IN CRL, DEFICIENCIES CITED BY FDA WERE ISOLATED TO ITEMS RELATED TO CHEMISTRY, MANUFACTURING, AND CONTROLS PROCESSES\n* EVOLUS INC - EXPECTS TO RESPOND TO FDA ABOUT CRL WITH A COMPLETE SUBMISSION TO FDA WITHIN 90 DAYS\n* EVOLUS INC - LOOK FORWARD TO WORKING CLOSELY WITH FDA AND REMAIN COMMITTED TO BRINGING DWP-450 TO MARKET BY SPRING 2019\n* EVOLUS INC - DWP-450 MANUFACTURING FACILITY HAS CAPACITY EXPECTED TO MEET ANTICIPATED PRODUCT DEMAND Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)\n ",
    "published": "2018-05-16T20:41:00.000+03:00",
    "crawled": "2018-05-17T14:28:14.016+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "evolus",
        "inc",
        "evolus",
        "announces",
        "progress",
        "regulatory",
        "submission",
        "evolus",
        "inc",
        "conference",
        "call",
        "scheduled",
        "et",
        "pt",
        "evolus",
        "inc",
        "evolus",
        "receives",
        "fda",
        "complete",
        "response",
        "letter",
        "comment",
        "isolated",
        "cmc",
        "item",
        "evolus",
        "inc",
        "plan",
        "utilize",
        "daewoong",
        "facility",
        "support",
        "commercial",
        "production",
        "following",
        "anticipated",
        "approval",
        "evolus",
        "inc",
        "fda",
        "issue",
        "favorable",
        "eir",
        "letter",
        "related",
        "manufacturing",
        "facility",
        "evolus",
        "inc",
        "manufacturing",
        "facility",
        "fully",
        "validated",
        "daewoong",
        "current",
        "good",
        "manufacturing",
        "practice",
        "requirement",
        "evolus",
        "inc",
        "crl",
        "deficiency",
        "cited",
        "fda",
        "isolated",
        "item",
        "related",
        "chemistry",
        "manufacturing",
        "control",
        "process",
        "evolus",
        "inc",
        "expects",
        "respond",
        "fda",
        "crl",
        "complete",
        "submission",
        "fda",
        "within",
        "day",
        "evolus",
        "inc",
        "look",
        "forward",
        "working",
        "closely",
        "fda",
        "remain",
        "committed",
        "bringing",
        "market",
        "spring",
        "evolus",
        "inc",
        "manufacturing",
        "facility",
        "capacity",
        "expected",
        "meet",
        "anticipated",
        "product",
        "demand",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}